Pharmaceuticals · Pharmaceuticals: Major · NSE: AMANTA · data 2026-10-30

Amanta Healthcare Limited

₹163.56-4.29% on 30 OctHealth: Average 5.3/10

Feb 2026Low ₹95.03 · High ₹207.08+56.2%

In plain words

Price: 22.1% below its 52-week high of ₹209.95.

Delivery: 52.4% of traded shares were kept for delivery over the last 10 sessions, against 52.6% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹163.56

Market cap

₹661 cr

P/E

43.3

P/B

—

ROE

9.4%

ROCE

11.5%

Debt / equity

1.11

Dividend yield

0.00%

1-year return

33.5%

52-week high

₹209.95

52-week low

₹92

Operating margin

14.0%

Growth

Revenue (last 12 months)	₹291 cr
Net profit (last 12 months)	₹15 cr
Sales growth, 3 years (yearly)	3.5%
Profit growth, 3 years (yearly)	—

Smart-money activity

11/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 6/15: 0 insider buy days (promoter group among them) and 1 SAST acquisition day in 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Insider ● Results

8 Oct 26Insider SAST disclosure: Kirit Amablal Desai acquired 1,50,400 shares -9.5% next session
5 Aug 26Results Results board meeting -0.1% next session
19 May 26Results Results board meeting +0.4% next session
10 Feb 26Results Results board meeting +2.9% next session
11 Nov 25Results Results board meeting +2.2% next session
26 Sept 25Results Results board meeting +0.6% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Amanta Healthcare Limited debt-free?

Its latest reported debt-to-equity ratio is 1.11, meaning borrowings are larger than shareholders' equity.

What is Amanta Healthcare Limited's P/E ratio?

About 43.3, based on the last 12 months' earnings and a price of ₹163.56 (data 2026-10-30).

What is the 52-week high and low of Amanta Healthcare Limited?

The 52-week high is ₹209.95 and the 52-week low is ₹92.

Similar companies

Kilitch Drugs (India) Limited (KILITCH) · Hexagon Nutrition Limited (HEXAGON) · Valiant Laboratories Ltd. (VALIANTLAB) · Wanbury Limited (WANBURY) · Praveg Limited (PRAVEG)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AMANTA in NSE Scanner →